References
- Cuzick J, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003;361(9354): 296–300.
- Freedman AN, et al. Estimates of the number of US women who could benefit from Tamoxifen for breast cancer chemoprevention. Journal of the National Cancer Institute 2003;95:526–532.
- Port ER, et al. Patient reluctance toward tamoxifen use for breast cancer primary prevention. Ann Surg Oncol 2001;8:580–585.
- Tchou J, et al. Acceptance of tamoxifen chemoprevention by physicians and women at risk. Cancer 2004;100:1800–1806.
- Freedman AN, et al. Tamoxifen use for breast cancer chemoprevention among US women. European Journal of Cancer Supplement 2004;2:17–18.